Pharma H1 exports up 5% to $16.14-bn. as Europe offsets U.S. slowdown
The next phase of growth should focus on moving up the value chain… will require greater investment in R&D, technology transfer and co-development of complex generics, biosimilars and specialised therapies. India’s pharmaceutical exports rose 4.90% year-on-year (YoY) to $16.14 billion in the first half of FY27, as strong demand from Europe, Latin America and ASEAN…
Read More “Pharma H1 exports up 5% to $16.14-bn. as Europe offsets U.S. slowdown” »